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Echistatin is a potent antagonist of the integrins αvβ3, α5β1 and
αIIbβ3. Its full inhibitory activity depends on an RGD (Arg-Gly-
Asp) motif expressed at the tip of the integrin-binding loop and on
its C-terminal tail. Previous NMR structures of echistatin showed
a poorly defined integrin-recognition sequence and an incomplete
C-terminal tail, which left the molecular basis of the functional
synergy between the RGD loop and the C-terminal region un-
resolved. We report a high-resolution structure of echistatin and
an analysis of its internal motions by off-resonance ROESY
(rotating-frame Overhauser enhancement spectroscopy). The full-
length C-terminal polypeptide is visible as a β-hairpin running
parallel to the RGD loop and exposing at the tip residues Pro43,
His44 and Lys45. The side chains of the amino acids of the RGD
motif have well-defined conformations. The integrin-binding loop
displays an overall movement with maximal amplitude of 30◦.
Internal angular motions in the 100–300 ps timescale indicate
increased flexibility for the backbone atoms at the base of the in-
tegrin-recognition loop. In addition, backbone atoms of the
amino acids Ala23 (flanking the R24GD26 tripeptide) and Asp26
of the integrin-binding motif showed increased angular mobility,
suggesting the existence of major and minor hinge effects at the
base and the tip, respectively, of the RGD loop. A strong network
of NOEs (nuclear Overhauser effects) between residues of the
RGD loop and the C-terminal tail indicate concerted motions
between these two functional regions. A full-length echistatin–
αvβ3 docking model suggests that echistatin’s C-terminal amino
acids may contact αv-subunit residues and provides new insights
to delineate structure–function correlations.
Key words: RGD disintegrin, echistatin, integrin, NMR protein
dynamics determination, off-resonance rotating-frame Over-
hauser enhancement spectroscopy (off-resonance ROESY).
INTRODUCTION
Venoms from Viperidae (vipers) and Crotalidae (rattlesnakes)
snakes contain a number of different proteins that interfere with
the coagulation cascade, the normal haemostatic system and tissue
repair. Consequently, envenomations by these snakes generally
results in persistent bleeding. Haemorrhage is the result of the syn-
ergistic action of certain metalloproteinases that degrade the extra-
cellular matrix surrounding blood vessels and proteins that inter-
fere with haemostasis. These proteins can be grouped into a few
major protein families, including enzymes (serine proteinases,
Zn2+-dependent metalloproteinases of the reprolysin family and
group II phospholipase A2 isoenzymes) and proteins with no en-
zymic activity (C-type lectins and disintegrins) [1,2].
Snake venom haemorrhagic metalloproteinases have been clas-
sified into four classes, according to their domain structure [3].
PI metalloproteinases (20–30 kDa) are single-domain proteins
with relatively weak haemorrhagic activity. The class PII metal-
loproteinases (30–60 kDa) contain a disintegrin domain at the
C-terminus of a metalloproteinase domain structurally similar
to that in the class PI. Haemorrhagins of the PIII class are
large toxins (60–100 kDa) with the most potent activity, and
comprise multidomain enzymes built up by an N-terminal metal-
loproteinase domain and C-terminal disintegrin-like and cysteine-
rich domains. The metalloproteinases of the PIV group contain
the mosaic structure of the PIII haemorrhagins and an additional
C-type lectin module disulphide-bonded to the cysteine-rich
domain.
Disintegrins are released in the venoms by proteolytic pro-
cessing of PII metalloproteinases [4], and inhibit integrin–ligand
interactions. According to their polypeptide length and the num-
ber of disulphide bonds, disintegrins have been classified into
five groups, including monomeric (short, medium-sized, long and
PIII) and dimeric proteins [5]. The structural diversity of disin-
tegrins has been achieved during evolution through the selective
loss of disulphide bonds [5]. The integrin inhibitory activity of
disintegrins depends on the appropriate pairing of cysteine resi-
dues which determine the conformation of the inhibitory loop. In
most single-chain disintegrins, the active sequence is the tripeptide
RGD (Arg-Gly-Asp) [5,6]. RGD-containing disintegrins show
different binding affinity and selectivity towards integrins, which
recognize the RGD sequence in their ligands [7] (i.e. αIIbβ3,
the platelet fibrinogen receptor; αvβ3, the vitronectin receptor;
and α5β1, the fibronectin receptor). Structural studies of several
short (echistatin) and medium (kistrin, flavoridin, albolabrin, sal-
mosin and trimestatin) RGD-disintegrins revealed that the active
tripeptide is located at the apex of a mobile loop protruding 14–
17 Å (1 Å = 0.1 nm) from the protein core [8–13].
Echistatin, a 49-residue RGD-containing peptide isolated from
the venom of the saw scaled viper (Echis sochureki carinatus)
[14], is the most thoroughly characterized disintegrin. Residues
adjacent C-terminally to the primary integrin-binding motif of
echistatin, R24GD26, contribute to the selective inhibition of αIIbβ3,
αvβ3 and α5β1 integrins by echistatin [15]. Thus, whereas tryp-
tophan favours the recognition of αIIbβ3 at position 27, aspartic
acid appears to be critical for inhibiting integrins αvβ3 and α5β1.
Abbreviations used: NOE, nuclear Overhauser effect; R.M.S.D., root mean square deviation; ROESY, rotating-frame Overhauser enhancement spectro-
scopy.
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In addition, replacement of Met28 with asparagine completely
abolished echistatin’s ability to block each of these disintegrins,
while substitution of leucine for Met28 selectively decreased the
inhibitory activity of echistatin towards integrin α5β1 only. A
number of studies also support a functional role for the C-ter-
minal residues of echistatin in modulating the binding affinity of
the disintegrin towards integrin αIIbβ3. Hence, an echistatin C-ter-
minal synthetic peptide inhibited the binding of echistatin to
integrin αIIbβ3, activated the integrin to bind immobilized ligands,
induced the expression of activation-dependent conformational
epitopes and increased fibrinogen binding to peptide-treated plate-
lets [16]. In addition, deletion of the sequence P40RNP43 (Pro40-
Arg-Asn-Pro43) and replacement of echistatin’s C-terminal se-
quence [H44KGPAT49 (His44-Lys-Gly-Pro-Ala-Thr49)] with that
of eristostatin [WNG (Trp-Asn-Gly)] [15–17] both decreased the
inhibitory potential of the mutated echistatin on ADP-induced
platelet aggregation. As a whole, these data indicate that the
C-terminal tail may act in synergy with the integrin-binding
loop to endow echistatin with high affinity and selectiveness for
integrin receptors.
In medium-resolution NMR solution structures of echistatin
reported previously [8,16–20] [PDB (Protein Data Bank) acces-
sion 2ECH], the N- and the C-terminal polypeptide stretches
and the loop bearing the RGD recognition sequence show large
dispersion, and from residue 42 onwards the protein is essen-
tially disordered. These structural features, which have been
interpreted as a realistic representation of the relative disorder of
these regions in solution, precluded an in-depth understanding
of the conformation and the relative orientation of the functional
epitopes of echistatin. We have reported recently the solution
structure [21] and internal backbone angular motions [22] of the
short disintegrin obtustatin from the venom of Vipera lebetina
obtusa (PDB code 1MPZ). The major finding from these studies
was that the integrin-binding loop and the C-terminal tail dis-
played concerted motions in the 100–300 ps timescale, which can
be interpreted by hinge movements articulated at residues located
at the base of the integrin-binding loop (Trp20, His27, Tyr28) and in
the C-terminal tail (Cys36 and Leu38). Since obtustatin and
echistatin share identical disulphide connectivities and are highly
homologous, a similar type of hinge motion may be expected.
The aims of the present study were to refine the structure of
echistatin, and to analyse in detail the internal motions of the back-
bone and side chain atoms of the disintegrin by homonuclear NMR
using spectra recorded with triple-resonance cryogenic probes at
500 and 600 MHz. In contrast with previous models, our results
show that the full-length C-terminal region and the active loop
of echistatin have well-defined conformations. The C-terminal
tail of echistatin folds as a β-hairpin running parallel to, and
displaying concerted motions with, the RGD loop. These two
functional regions of echistatin form a conformational epitope that
is engaged in extensive interactions with target integrin receptors.
MATERIALS AND METHODS
Sample preparation
Echistatin was purified from Echis carinatus sochureki venom,
purchased from Latoxan (Valence, France), by reversed-phase
HPLC as described in [14]. Protein purity was assessed by
SDS/PAGE, N-terminal sequencing (with an Applied Biosystems
Procise 492 sequencer) and MALDI–TOF (matrix-assisted laser-
desorption ionization–time-of-flight) MS (using an Applied
Biosystems DE-Pro spectrometer and α-hydroxycinammic acid
saturated in 70% acetonitrile, containing 0.1% trifluoroacetic
acid as the matrix). The complete amino acid sequence was
Table 1 Summary of meaningful structural restraints
Type Number





Side chain–side chain 47
Medium range (less than four residues apart) 120
Backbone–backbone 32
Backbone–side chain 37
Side chain–side chain 51
Long range 172
Disulphide bond constraints 4
determined in a single run, and it was identical with that of entry
P17347 of the SwissProt database (http://us.expasy.org/sprot).
The isotope-averaged molecular mass of echistatin was 5417 Da,
and this value did not change upon incubation of the protein
(5 mg/ml in 100 mM ammonium bicarbonate, pH 8.5, containing
5 M guanidinium chloride) with 50 mM iodoacetamide, indi-
cating that the eight cysteine residues of echistatin were engaged
in disulphide bonds. For NMR structure determination, echistatin
was dissolved in H2O/2H2O (19:1) at a final concentration of
3 mM in a 5 mm Wilmad NMR tube. The solution was adjusted
to pH 3.0 with HCl.
NMR spectroscopy
All two-dimensional spectra were recorded on Bruker Avance
spectrometers working at proton frequencies of 500 and 600 MHz.
Triple-resonance cryogenic NMR probes were used for all the
measurements. Spectra were processed with XWIN-NMR, ver-
sion 3.1, and analysed with SPARKY [23] software packages on
a Pentium 4 workstation running the Linux operating system.
Homonuclear two-dimensional spectra for structure determin-
ation were recorded at 298 K and included NOESY spectra at
500 and 600 MHz, with 100 and 200 ms of mixing time. In these
experiments, solvent signal suppression was achieved by using
the WATERGATE pulse sequence [24]. Recycling relaxation
delay between transients was 2 s in all the NOESY spectra.
Assignments of NOESY and ROESY (rotating-frame Overhauser
enhancement spectroscopy) cross-peaks for structure determin-
ation and off-resonance ROESY relaxation analysis were assigned
using echistatin resonances from the BioMagResBank (BMRB
entry 2204 at http://www.bmrb.wisc.edu) with minor corrections.
Structure calculations
An initial set of unambiguous, non-overlapped NOE (nuclear
Overhauser effect) cross-peaks was assigned manually. A pre-
liminary set of structures was then obtained and used for further
NOE cross-peak assignment by semi-automated analysis with the
NOAH routine implemented in the DYANA software package
[25]. Structural restraints used for NOAH semi-automated
analysis included only the well-established disulphide bonds
(Cys2–Cys11, Cys7–Cys32, Cys8–Cys37 and Cys20–Cys39) [26,27]
and the manually assigned NOEs. These restraints were included
in the calculation at the first cycle. The new set of extended
structural restraints was then applied in further cycles of DYANA
simulated annealing torsion angle dynamics for the generation
of the final conformers. The final set of assigned NOE cross-
peaks included a total of 977, of which 440 were structurally
meaningful (Table 1). The 20 conformers with the best DYANA
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target function were refined further with one cycle of simulated
annealing standard protocol in XPLOR [28]. All the calculation
parameters concerning the simulated annealing protocol (i.e.
NOE and van der Waals weighting, temperature, dielectric con-
stants, and rates of heating and cooling) were set to the default
values recommended by the user manual of the software.
An overall amplitude of motion for the recognition loop was
calculated based on the best 20 energy-refined DYANA models.
In a first step, the disulphide cores of the molecules were super-
imposed. Then the disulphide core atom closest to the recognition
loop (atom A) and the recognition loop atom furthest from the core
(atom B) were identified. A triangle was built using the positions
of atom A and the most distant positions of atom B (positions B1
and B2). The angle between the lines A–B1 and A–B2 was taken
as the amplitude of motion of the loop.
Off-resonance ROESY relaxation analysis
Internal motions were analysed using the off-resonance ROESY
method described by Schleucher and Wijmenga [29]. Briefly,















f (r)[2J (0) + 3J (ω)] (2)
where f (r) depends only on the radial component of internal
motions, whereas J(ω), the spectral density function, depends
only on the angular component of the internal motions. Thus the
ratio of NOE and ROE (rotating-frame Overhauser effect) rates is
considered to be independent of the radial component:
R = σNOE
σROE
= 6J (2ω) − J (0)
2J (0) + 3J (ω) (3)
In a ROESY experiment, the angle θ i at which a spin i with a
chemical shift i will be locked by a spin lock of field strength
γ B1 and an offset 	 is defined by:
θi = arctan[γ B1/(i − 	)] (4)
Unmodified NOESY and ROESY spectra can be associated
with values of the θ angle equal to 0◦ and 90◦ respectively. There-
fore the angle at which the NOE and ROE effect contributions
are equal, and thus the spectral signal is cancelled, provides a
measure of the ratio R:
0 = σeff(θ 0) = c(θi , θ j )(σNOE · cos2 θ 0 + σROE · sin2 θ 0) (5)
where c(θ i, θ j) is a scaling factor that does not affect the θ 0 value.
R can be determined measuring the value of θ at which the NOE




= − tan2 θ 0 (6)
Since the spectral density J(ω) depends only on the angular
component of internal motions (eqn 3), low and high values of θ 0
are inversely proportional to the degree of angular flexibility of a
given vector.
Variations of θ 0 values are largest for motions in the timescale of
100 –300 ps and therefore these motions are the main contributors
Table 2 Experimental parameters used for recording off-resonance ROESY
spectra at 500 and 600 MHz proton frequencies
500 MHz 600 MHz
Offset (Hz) θ c* (◦) Offset (Hz) θ c* (◦)
21 000 21.0 22 200 25.5
18 000 24.6 20 000 28.0
16 000 27.7 18 200 31.0
15 000 29.6 16 500 34.0
13 000 34.0 15 000 37.0
11 000 39.9 14 200 39.1
10 000 43.1 13 100 42.0
12 000 45.0
11 100 48.2
* θ c is the value of θ of the frequency at the middle of the spectrum.
to the internal dynamics detected in the present study. In this
timescale (τ e values of 100 –300 ps), θ 0 appears to exhibit a
parallel behaviour to the maximum of the S2 Lipari–Szabo order
parameter. Thus θ 0 provides an estimation of the relative angular
flexibility for a given NOE vector in a similar fashion to that
extracted from relative differences in S2 for the 15N–1H or 13C–1H
bond vectors in traditional heteronuclear relaxation studies.
For the determination of internal motions of echistatin, an in-
dependent set of off-resonance ROESY spectra was recorded on
each spectrometer at 298 K as described in [22,29]. In general,
experimental parameters were as similar as possible to those
reported previously for obtustatin [22]. Relaxation delay was
3.0 s including pre-saturation of water resonance. All ROESY
experiments were recorded with a mixing time of 100 ms, spectral
width of 10 p.p.m. and transmitter offset at the water position
equivalent to 4.69 p.p.m. at 25 ◦C. For each experiment, 512 t1
and 2048 t2 complex data points were acquired. All experiments
had 32 scans. For detecting positive cross-peaks, as an indicative
of chemical exchange processes, a regular ROESY (on-resonance)
was recorded at each spectrometer with parameters identical with
those of the off-resonance ROESY experiments. Values for γ B1
were 7180 and 9259 for the 500 and 600 MHz experiments
respectively, corresponding to approx. 50% of the used spectral
width, as recommended in the literature [29]. Table 2 shows values
of frequency offsets and equivalent θ values at the transmitter
frequency (middle of the spectrum) used in all off-resonance
ROESY experiments for evaluation of the optimum range of offset
frequencies. ROESY cross-peaks were fitted to Lorentzian curve
peak shapes and integrated using SPARKY internal commands.
ROESY cross-peaks showing severe overlapping or very low
signal-to-noise ratios were discounted from further analysis.
Graphical representation, second-order polynomial fitting and
zero-crossing identification for cross-peak intensity against θ
dependence were carried out using home-made Gnuplot macros
(http://www.gnuplot.info/) and UNIX shell scripts.
Hydrodynamic calculations
For comparison with experimental data and for an initial
estimation of the global correlation time τm, HydroNMR version
5.a software [30] was employed with the echistatin’s NMR
structure reported in the present study (PDB code 1RO3). Strong
cross-linking by four disulphide bonds along with an R.M.S.D.
(root mean square deviation) value of 1.2 Å for all residues among
the 20 NMR conformers of echistatin (0.7 Å for the 32 best-de-
fined residues) indicated that echistatin fulfils the level of overall
structure globularity and rigidity required for this type of analysis.
Temperature and solvent viscosity for calculations were set to
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25 ◦C and 0.010 poises respectively, as recommended in the
software manual. Theoretical rigid limit values of θ 0 for each
set of off-resonance ROESY experiments were estimated using
the calculated value of τm.
Surface electrostatic potential
The surface electrostatic potential distribution of the best overall
model of echistatin was calculated with MOLMOL [31], based
on simple Coulomb interactions and implicit hydrogen atom
positions. Solvent-accessible surface was calculated using the
MOLMOL surfaces command with default parameters. Atom
charges and the protonation state of the amino acids were derived
with the “pdb charge” MOLMOL macro.
Docking of echistatin into integrin αVβ3
A model for the integrinαVβ3–echistatin complex was constructed
by simulation using the docking program HADDOCK [32] and
the co-ordinates of the αVβ3 integrin extracellular domains (αV
residues 1–439; β3 residues 55–434) in complex with a cyclic
RGD pentapeptide (PDB code 1L5G). In a first stage, HADDOCK
calculated 500 conformations using a rigid-body docking pro-
tocol. Next, the best 100 structures in terms of their inter-mol-
ecular energies were refined by simulated annealing in two stages.
AIR (Ambiguous Interaction Restraints) [32] were derived from
the known interactions of the RGD motif of the cyclic penta-
peptide in the PDB structure 1L5G. Initial constraints were
contacts between the arginine residue and αv residues Asp150,
Tyr178, Thr212, Gln214 and Ala215, and between the aspartate residue
of the RGD motif and β3 residues Arg216 and Ala218 and with
the MIDAS Mn2+. Both, the side-chains and the backbone atoms
at the interface (including residues 149–152, 176–181, 211–216
and 217–219 of αV, residues 120–124 and 212–221 of β3, and
residues 23–27 and 44–46 of echistatin) were allowed to move in
a semi-rigid-body docking protocol to search for conformational
rearrangements. Using these parameters, the standard HAD-
DOCK protocol for protein docking was applied with minor modi-
fications. This protocol combines several stages of molecular
dynamics calculations, including heating and cooling with a pro-
gressive increase of the flexibility at the binding interface. The
resulting 50 molecules with the lowest intermolecular energy
values were refined with explicit solvent molecules included.
The structures were classified by clustering using the pairwise
R.M.S.D. differences.
RESULTS AND DISCUSSION
NMR structure of echistatin
Two-dimensional NMR spectra of echistatin (∼3 mM, pH 3.0,
25 ◦C) showed good chemical shift dispersion in the HN–Hα
region, which allowed the straightforward assignment of non-
overlapped cross-peaks. Assignments of NOESY and ROESY
cross-peaks for structure determination and off-resonance
ROESY relaxation analysis were obtained on the basis of pre-
viously published data [20], as described in the Materials and
methods section. Overall, chemical shifts observed in our spectra
were in good agreement with those obtained from the BMRB
database (BMRB 2204), although minor differences were detected
for some cross-peaks. Statistics on echistatin NOE assignments
and structure calculations are shown in Tables 1 and 3 respectively.
The atomic co-ordinates of the final 20 lowest energy conformers
of echistatin are accessible from the PDB under the code 1RO3.
Figure 1 shows the superposition of the final 20 lowest energy
Table 3 Structural statistics for the best 20 energy-refined DYANA NMR
conformers of echistatin
Statistic Value
Residual DYANA target function value (A˚) 1.12 +− 0.21
Residual NOE distance constraint violations
>0.2 A˚ 9 +− 4
Maximum (A˚) 0.22 +− 0.09
Residual disulphide bond constraint violations
>0.2 A˚ 0
Maximum (A˚) 0
Residual van der Waals close contacts violations
>0.2 A˚ 3 +− 1
Maximum (A˚) 0.22 +− 0.04
R.M.S.D. from ideal geometry
Bond length (A˚) 0.0089 +− 0.0005
Bond angles (deg.) 1.37 +− 0.41
R.M.S.D. N, Cα , C’ (3–19, 29–47) to mean co-ordinates (A˚) 0.511 +− 0.101
R.M.S.D. N, Cα , C’ (21–31) to mean co-ordinates (A˚) 0.621 +− 0.142
R.M.S.D. heavy atoms (3–19, 29–47) to mean co-ordinates (A˚) 1.051 +− 0.291
Residues distribution on Ramachandran plot
In allowed regions 714 (76.0 %)
In unfavourable regions 151 (16.1 %)
In disallowed regions 75 (8.0 %)
conformers of echistatin (1RO3; Figure 1A) compared with the
best eight models reported in previous structural studies on
echistatin (2ECH; Figure 1B). The R.M.S.D. for the backbone
atoms between the mean structures of 1RO3 and 2ECH was 4.1 Å,
and this value was reduced to 2.6 Å if amino acid residues 3–
19 and 29–47 only were taken into consideration. The structural
elements that define the strongly disulphide-bonded core of the
protein are mainly conserved in both structures, although it is evi-
dent that both echistatin models depart in structural features that
are discussed below.
NOESY cross-peaks in the side chain proton region were of
critical importance for obtaining a defined conformation for the
C-terminal tail region (Figure 2). The detection of very weak
long-distance NOEs between residues in the active loop and the
C-terminal region was achieved using cryoprobes. Subsequent
cycles of semi-automated NOE assignment process detected a
not-previously reported strong network of NOEs between these
two structural elements. Distribution of the final set of long-range
NOE restraints along the whole amino acid sequence of echistatin
is shown in Figure 3, where the network of NOEs between the
C-terminal region and the rest of the protein can be appreciated.
A compact globular core maintained by a tight network of
disulphide bonds, from which several loops protrude, defines the
structure for echistatin depicted in Figure 1(D). An irregular loop
similar to a β-hairpin harbours the recognition RGD tripeptide at
its tip. Disulphide bonds linking residues Cys2–Cys11 and Cys20–
Cys39 were confirmed by observation of Hβ–Hβ long-distance
NOEs. The sequential and spatial proximity of Cys7 and Cys8
make it very difficult to confirm the remaining two disulphide
bonds unambiguously by NMR. However, disulphide bridges
have been determined previously by chemical methods [26,27]
and therefore were also included as structural restraints. Although
the above structural features have been described previously
for the echistatin structure 2ECH, the refined NMR structure of
echistatin in the present paper also significantly departs from
the echistatin structure reported previously. A major distinct
feature of the echistatin models 2ECH and 1RO3 is that, in the
latter, the full-length C-terminal polypeptide is visible and folds as
a β-hairpin running parallel to the RGD loop and exposing at the
tip residues Pro43, His44 and Lys45. In addition, the side chains
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Figure 1 NMR confirmation and structural features of full-length echistatin
(A) The best 20 three-dimensional structures of echistatin (PDB code 1RO3) superimposed over the backbone of well-defined residues (3–19 and 29–41). (B) The best eight models of the previously
reported echistatin (PDB code 2ECH) superimposed over the backbone of well-defined residues (3–19 and 29–41). In (A) and (B) the residue backbone and side-chain atoms of the recognition
R24GD26 motif have been plotted in red. (C) Representation of the surface electrostatic potential of echistatin (PDB code 1RO3) calculated using the MOLMOL program [31]. Positively and negatively
charged areas are coloured blue and red respectively. The RGD motif and residues Pro43, His44 and Lys45 located at the tip of the integrin-binding loop and C-terminal loop respectively are circled.
(D) Cartoon of the echistatin (PDB code 1RO3) mean structure in the ‘sausage’ representation and colour-coded according to the flexibility calculated from mean-normalized θ 0 values. Values of θ 0
for backbone Hα–HN NOEs have been mapped on N atoms, while θ 0 values for sequential NOEs have been mapped on Cα and carbonyl atoms. θ 0 values are associated with the following colours:
red, θ 0 < 0.75; orange, 0.75 <θ 0 < 0.85; green, 0.85 <θ 0 < 0.95; dark blue, θ 0 > 0.95. Light blue indicates absence of data. Disulphide bonds are represented by yellow wires.
of residues in the active tripeptide (Arg24 and Asp26) are well-
defined and are exposed to the solvent. Local R.M.S.D. values
for backbone atoms suggest that mobility is conferred to the re-
cognition site by a slight hinge effect located at the basis of the
loop similar to that previously reported for obtustatin [22], a close
homologue of echistatin. The amplitude of the motion of the
active loop in the NMR structure of echistatin reported here is
approx. 30◦, shorter than that reported for obtustatin (35◦ [22])
and in marked contrast with the value of 60–70◦ previously de-
scribed for the echistatin structure 2ECH [8]. A small network of
hydrogen bonds keeps the conformation of the protruding active
loop in a similar fashion to that observed in β-hairpin struc-
tures. In obtustatin, whose recognition loop is three residues
shorter than in echistatin, and which does not display any regular
secondary structure, a single hydrogen bond keeps the loop ac-
tive conformation [22]. Although echistatin appeared to have an
overall less flexible recognition loop than that observed in obtu-
statin, high R.M.S.D. values for the backbone atoms of residues
Arg24, Gly25 and Asp26 suggested an increased flexibility for the
active tripeptide, which may partially compensate for the shorter
degree of overall motion of the active loop, providing further
mobility to the integrin-recognition motif (see below).
An analysis of the conformation of the C-terminal region of
echistatin showed details that were worth noticing. The length
of the C-terminal region of echistatin is quite similar to that
observed for the C-terminal tail of obtustatin, and residues Pro43
and Gly46 of echistatin occupy equivalent positions as Pro40 and
Gly41 in obtustatin. However, unlike obtustatin, the R.M.S.D.
values for backbone atoms of the C-terminal region of echi-
statin do not suggest the existence of a hinge motion within
the C-terminal tail. Overall, the NMR structure of echistatin
in the present paper shows a compact solvent-accessible surface
(Figure 1C). Charges within the RGD loop of echistatin
(C20KRARGDDMDDYC32) are not evenly distributed, with posi-
tive electrostatic potential upstream of Arg24 and negative poten-
tial downstream of Asp26. The net positive electrostatic character
of the C-terminal tail of echistatin, running parallel to the posi-
tively charged stretch of the RGD loop, contributes further to
this charge segregation (Figure 1C), which may have functional
relevance.
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Figure 2 Side-chain proton region of the NOESY spectra of echistatin
The spectra were recorded at 600 MHz and at 25◦C with 200 ms of mixing time. Critical NOE
cross-peaks for close contacts between the C-terminal tail and the rest of the protein have been
labelled.
Figure 3 Plot of the number of NOE assigned cross-peaks used in the
structure calculations
Intra-residual (black), sequential (dark grey), short-range (less than four residues apart, light
grey) and long-range (white) NOE assigned cross-peaks used in the structure calculations are
shown, along with the amino acid sequence of echistatin.
Internal motions and θo values
Recently, new methods for the detection of internal motions by
homonuclear NMR have been developed [29] that allow the
study of motions in a wider spatial range than traditional 15N
or 13C relaxation methods analysing the proton–heteronucleus
bond. Also worthy of notice is that homonuclear NMR methods
overcome the need for isotopic labelling of the samples, thus
allowing the study of molecules isolated from natural sources.
Although many dynamics studies on proteins using natural
abundance 13C relaxation have been reported in the literature
[33,34], the outcomes usually refer to very local dynamics (one-
bond and methyl groups), and phenomena such as hinge effects
or co-ordinated motions can hardly be detected. In the case of
disintegrins, this kind of motion has been reported previously [22]
and therefore a longer range of dynamics study over traditional
one-bond relaxation measurements is preferred.
Off-resonance ROESY data for echistatin were analysed with
protocols and homemade scripts as described previously for the
characterization of internal angular motions in the 100–300 ps
time scale of the disintegrin obtustatin [22]. A total of 126 assigned
cross-peaks from 16 off-resonance ROESY spectra recorded at
two magnetic fields were analysed. Cross-peak intensities were
fitted to a second-order polynomial function of the θ value, θ zero-
crossing point was calculated, and θ 0 values were averaged for
each magnetic field and normalized with respect to the theoretical
rigid limit. The theoretical global correlation time of echistatin
1RO3, calculated with the HydroNMR software, was 3.7 ns. This
value is in good agreement with previously calculated correlation
times reported in the literature (4.1 +− 0.5 ns) [19].
Differences in the average normalized value of θ 0 can be cor-
related with differences in S2 [22], and values of mean normalized
θ 0 for sequential and intra-residue HN–Hα ROE cross-peaks
indicate the flexibility of ψ and  dihedral angles respectively.
Higher values of θ 0 indicate lower angular mobility. These values
have been mapped on the three-dimensional structure and the
amino acid sequence in Figures 1(D) and 4 respectively. On
the other hand, analysis of intra-residue HN–Hβ , Hα–Hβ and Hα–
Hγ ROE cross-peaks provides information on the flexibility of
side chains. Values of θ 0 for the most relevant side chains in
echistatin are reported in Table 4. Several long-range ROE cross-
peaks have been analysed to study relative motions of different
structural elements. Values of θ 0 for these cross-peaks are also
shown in Table 4.
In general, the NMR structural dispersion along the amino acid
sequence is in good agreement with the flexibility values derived
from θ 0. Minor differences involve the RGD motif. Values of θ 0
for this region are higher than at the base of the loop and lower
than in the intervening loop stretches, invoking a minor hinge
effect also suggested by local R.M.S.D. values. Other regions of
echistatin showing increased flexibility include the residues Glu3,
Ser4, Arg9 and Lys12 which are solvent-exposed as calculated with
PROCHECK [35], and the backbone atoms of residues Gly17,
Thr18 and Asp29, located at the base of the integrin binding loop
(Figures 1D and 4). Residues in the tip of the recognition
loop, including the RGD motif, also show some degree of flex-
ibility. The increased backbone flexibility at the base of the RGD
loop suggested that the mobility of the RGD loop might be due
to a hinge effect articulated at the base of the loop, similar to
that reported for obtustatin [22]. On the other hand, hydrogen-
bonded core residues and cysteines that are engaged in disul-
phide bonds show, as expected, restricted mobility. Analysed long-
range intra-loop ROE cross-peaks are listed in Table 4. Angular
mobilities of these ROE vectors are partially restricted, reflecting
their engagement in the hydrogen-bond network that maintains
the recognition loop in its active conformation.
Internal motions in the C-terminal region of echistatin 1RO3
are significantly restricted. Hence, the backbone atoms of residues
in the range 36–46 show values of θ 0 higher than those of
residues 47–49 and of residues located at the base of the integrin-
recognition loop. These θ 0 values, which indicate local restricted
angular mobility, are in good agreement with the low structural
dispersion in this region of the echistatin NMR structure. Unlike
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Figure 4 Internal angular motions of echistatin analysed by off-resonance
ROESY
(A) Plots of the θ 0 values for intra (black line) and sequential (grey line) backbone Hα–HN
cross-peaks measured at 500 (upper panel) and 600 (lower panel) MHz proton frequencies
along the amino acid sequence of echistatin. (B) Mean normalized θ 0 values for data at 500
and 600 MHz (upper panel) for intra (black) and sequential (grey) NOE Hα–HN cross-peaks
with experimental errors, compared with backbone atom co-ordinate R.M.S.D. values (lower
panel) from NMR solution structure (PDB code 1RO3), along with the amino acid sequence of
echistatin.
Table 4 Mean-normalized θ 0 values (averaged for data at 500 and 600 MHz)
for cross-peaks involving side chains of well-defined residues (w), amino
acids of the integrin-recognition site (r), C-terminal region residues (c) and
residues in disulphide bridging (ss)
NOE cross peak Normalized-mean θ 0
Glu3 HN–Hβ (w) 0.75 +− 0.05
Thr36 HN–Hβ (w) 0.77 +− 0.07
Lys14 HN–Hβ (w) 0.67 +− 0.11
Asn33 HN–Hβ (w) 0.79 +− 0.05
Leu14 Hα–Hβ (w) 0.71 +− 0.04
His44 HN–Hβ (c) 0.71 +− 0.05
Lys45 HN–Hβ (c) 0.68 +− 0.04
Arg41 HN–Hβ (c) 0.73 +− 0.06
Arg41 Hβ–Arg22 HN (c) 0.61 +− 0.06
Cys2 Hβ–Cys11 Hβ (ss) 0.79 +− 0.12
Cys20 Hβ–Cys39 Hβ (ss) 0.74 +− 0.08
Arg24 Hα–Hβ (r) 0.71 +− 0.08
Asp26 Hα–Hβ (r) 0.62 +− 0.09
Arg24 Hβ–Asp26 Hβ (r) 0.48 +− 0.29
in the case of obtustatin, no hinge effect has been detected in
the C-terminal region of echistatin. However, the short amplitude
of the recognition loop overall motion, along with the network of
long-range NOEs between residues of the RGD loop and the
C-terminal tail (Figure 3), indicate the existence of concerted
motions between the C-terminal and the RGD loops. It is also
worth mentioning the relative low degree of angular flexibility of
the side chains of amino acids His44 and Lys45 (θ 0 for HN–Hβ ROE
cross-peak of 0.71 and 0.68 respectively), which exhibit similar
spatial orientation to the lateral chains of residues Arg24 and Asp26
of the integrin-recognition motif.
Dynamics of the RGD recognition motif
Analysis of the angular mobility showed that the backbone atoms
of the amino acids of the R24GD26 motif are highly mobile in the
time scale measured. Amino acids Ala23 and Asp26 exhibited equal
or even higher levels of backbone angular mobility than residues
Arg24 and Gly25 (Figures 1D and 4), indicating that the enhanced
motion of the RGD motif at the tip of the integrin-binding loop
may be articulated at Ala23 and Asp26. This conclusion is in good
agreement with a previous 15N relaxation study of the active
tripeptide of echistatin [19]. In this 15N study, values of S2 for
Ala23, Gly25 and Asp26 were 0.29, 0.50 and 0.46 respectively,
indicating that Ala23 represents a more flexible residue than
those in the active site, therefore supporting the proposed small
hinge effect for the active-site-flanking amino acids. However, in
contrast with the aforementioned 15N relaxation study [19], our
results do not support a large amount of chemical exchange for the
amino acids in the active site. All analysed cross-peaks correspond
to negative intensities (opposite to diagonal sign) in a regular
ROESY spectrum, clearly indicating the absence of chemical
exchange in the millisecond timescale. It must be mentioned that
the values of Rex observed by 15N relaxation studies are in the range
of 0.1 to 1 s, and that the values of τ e for these residues measured
by 15N relaxation analysis (1.2–2.7 ns) belong to a much longer
timescale than that studied here (100–300 ps). Timescales of the
chemical-exchange processes measured in the present study and
in the 15N relaxation studies [19] are rather different, and therefore
both analyses may be considered as complementary.
On the other hand, the side-chain atoms of the echistatin’s
integrin-recognition tripeptide have limited mobility in com-
parison with other side chains of the protein (Table 4). Hence, ROE
cross-peaks Hα–Hβ for Arg24 and Asp26 display high values of θ 0,
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Figure 5 Docking model of αvβ3–echistatin complex
(A) Ribbon representation of a putative model of echistatin (blue) docked into the RGD-binding crevice of the globular head of integrin αvβ3 (PDB code 1L5G). The αV subunit β-propeller domain
has been coloured orange and the β3 subunit A- and thigh domains are in yellow. (B) Detail of the interaction region showing the molecules in the same colour and orientation as in (A). The side
chains of echistatin amino acids engaged in intermolecular contacts are plotted in the ball-and-stick representation and are labelled using the one-letter amino acid code. The β3 MIDAS Mn2+ ion
is depicted as a violet sphere. (C) A close-up stereo view of the modelled αvβ3–echistatin interaction region displayed in the same orientation as in (A) and (B). Interacting residues (Table 5) are
shown in the ball-and-stick representation, and the interactions, other than hydrophobic contacts, are displayed by broken lines.
0.71 and 0.62 respectively, indicating a well-defined side-chain
conformation. However, the ROE cross-peak Arg24 Hβ–Asp26 Hα
showed a very low value of θ 0 and a poor model fitting, which
is indicative of a mobile ROE vector and complex motions. The
mobility of the ROE vector linking side chains of the recognition
site clearly indicated the existence of complex mechanisms for the
flexibility of these residues. The proposed hinge effect articulated
at the active-site-flanking residues superimposed to the overall
motion of the whole integrin-binding loop may contribute to the
enhanced flexibility of the RGD motif side chains.
Docking model of αvβ3–echistatin complex
To gain structural insights into the inhibitory mechanism of
echistatin, a putative model for a echistatin–integrin αVβ3 com-
plex was built using HADDOCK 3.1 software and based on
the crystal structure of integrin αVβ3 complexed with a cyclic
RGD pentapeptide (PDB code 1L5G). HADDOCK calculations
provided a set of convergent structures for the disintegrin–integrin
complex. Specifically, four clusters of structures were obtained by
fitting them over the interacting RGD residues with an average
R.M.S.D. value for the backbone atoms of all the amino acids in
all echistatin–integrin complexes of less than 1 Å. The energies
of the four clusters were of the same order of magnitude,
although the mean energy of the cluster selected for calculating
Table 5 Possible intermolecular contacts between echistatin and αVβ3
Echistatin αV β3
Lys15 Met180, Lys181, Thr182
Arg22 Tyr178
Arg24 Asp150, Tyr178, Gln180, Asp218, Asp219




His44 Asp150, Ala215, Ile216, Asp218
Lys45 Gln214, Ile216
the docking model was 2-fold lower than the corresponding
value of the maximal mean energy cluster, and 25% lower than
the nearest cluster energy. Figure 5 displays the lowest energy
structure cluster of echistatin docked into the crevice between
the α and the β subunits of integrin αVβ3. The average buried
surface area of the complex interface is 1394 Å2. Table 5 shows
the intermolecular contacts of the proposed echistatin–integrin
αVβ3 complex. Among the residues of the integrin-binding motif,
Asp26 contacts only the β3 subunit through interactions with
Ser123 and the MIDAS cation, whereas Arg24 participates in an
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extensive network of interactions with αV residues. Noteworthy,
echistatin residues flanking the RGD motif at its C- and N-ter-
minal sites also interact selectively with the αv (Arg22) or the
β3 (Asp27, Met28, Asp29) subunit (Table 5 and Figure 5). These
residues may endow echistatin with its reported integrin-re-
cognition specificity and affinity. Moreover, with the exception
of the α1β1 inhibitory disintegrin obtustatin, the active tripep-
tides of all known disintegrins are flanked by positively (N-ter-
minus) and negatively (C-terminus) charged residues [6]. Such a
‘plug’-based integrin-blocking mechanism supports the view that
the conserved aspartate residue of the integrin-binding motifs
of disintegrins (RGD, KGD, MGD, VGD, WGD, MLD, with
the bold underlined residue indicating the conserved aspartate
residue of the integrin-binding motifs) might be responsible for the
binding of disintegrins to integrin receptors that share a β-subunit,
whereas the N-terminal residue of the integrin-binding motif may
dictate the integrin-inhibitory specificity through interactions with
the α-subunit propeller domain [6]. On the other hand, residues
located at the C-terminal side of the RGD motif determine the
affinity of disintegrins to integrins [15,36,37]. The observation
that replacement of Met28 with asparagine completely abolished
echistatin’s ability to block integrins αIIbβ3, αvβ3 and α5β1, while
leucine at position 28 only decreased the inhibitory activity of
echistatin towards integrin α5β1 [15], can be structurally explained
with the docking model shown in Figure 5, according to which
Met28 interacts with β-subunit residues (Table 5). On the other
hand, the report that, compared with wild-type, the synthetic mu-
tant Asp27 → Trp of echistatin showed increased inhibitory activ-
ity against platelet aggregation and decreased potency to block
vitronectin [38] has been interpreted on the basis of a trimestatin–
αvβ3 docking model in terms of a specific contact of the cor-
responding Phe52 residue of trimestatin with residues of the pro-
peller domain of αv [13]. However, comparison of the possible
contacts between trimestatin and αvβ3 (Table 1 of [13]), and be-
tween echistatin and the same integrin (Table 5), shows that, as
expected, they are conserved for conserved residues in the two
disintegrins (the arginine and the aspartate of the RGD motif),
but depart for those residues of both the RGD loop and the
C-terminal region, with different side chains in trimestatin and
echistatin. In particular, in the NMR structure of echistatin re-
ported in the present paper, the side chain of Asp27 points in the
opposite direction to its topologically equivalent Phe52 in the trim-
estatin structure, and makes contact solely with the β3 Mn2+ ion
(Figures 5B and 5C). Thus a drastic change in the spatial orien-
tation of the side chain of Trp27 in the echistatin mutant must be
invoked. Alternatively, the presence of tryptophan at position 27
may force a local reorientation of the disintegrin molecule in the
integrin RGD-binding crevice, with consequences for the inter-
action of the mutated echistatin with the α-subunit β-propeller
domain.
Noteworthy, despite the high degree of mobility allowed for
the binding loop residues in the HADDOCK calculations, the
backbone, as well as the side-chain atoms of the echistatin’s in-
tegrin-recognition site amino acids, show low local dispersion
in all the modelled disintegrin–integrin complexes. This strongly
suggests an induced-fitting mechanism for the binding of echi-
statin to its target integrin receptor.
The high-resolution structure of echistatin reported in the
present paper, and particularly the fact that, in contrast with a pre-
vious echistatin NMR structure, its full-length C-terminal poly-
peptide is visible and folds as a β-hairpin running parallel to, and
displaying concerted motions with, the RGD loop, prompted us
to use the disintegrin–integrin model to investigate the structural
grounds for the biological role of the C-terminal tail of echistatin.
His44 and Lys45 at the tip of the β-hairpin appear to be engaged
in a network of contacts with residues of the propeller domain of
the αV subunit. This is consistent with biochemical data showing
that deletion of the C-terminal region of echistatin reduced the
ability of the disintegrin to inhibit platelet aggregation [7,16], and
supports the view that the C-terminal tail contains determinants
of integrin-blocking specificity.
Our docking model does not support the conclusion derived
from cross-linking studies that the regions encompassing residues
109–118 and 209–220 represent contact sites in αvβ3 for echistatin
analogues, with a photoreactive group in positions 28 and 45 res-
pectively [39,40]. Residues 109–118 of β3 encompassing the
proposed cross-linking site for p-benzoylphenylalanyl–(28)echi-
statin (where 28 indicates the position of the cross-linker attach-
ment) correspond to the βA strand of the β3 A-domain [41], and
are completely buried in the domain core. However, in our docking
model (Figure 5), echistatin Met28 interacts with the β3 loop
residues Tyr122 and Lys125 (Table 5). On the other hand, in our pro-
posed echistatin–αvβ3 complex model, the closest distance be-
tween echistatin’s Lys45 and any residue within the β3 209–220
region is approx. 20 Å. Hence, a large change in the relative orient-
ation of the C-terminal region of echistatin upon binding to
integrin αvβ3 might be invoked to reconcile the docking and the
cross-linking models. However, the structure of the synthetic and
chemically modified echistatin molecule has not been reported,
and thus it is not clear whether it possess the same disulphide-
bonding pattern and three-dimensional conformation as the 1RO3
NMR structure reported in the present paper.
Concluding remarks
The homonuclear NMR study reported in the present paper
provides a refined structure and new insights into the dynamics
and the conformation of biologically relevant epitopes of echi-
statin. Major structural features that were not apparent in previous
echistatin structures are the overall hinge motion of the integrin-
binding loop and the superimposed local enhanced flexibility of
the RGD motif, and the conformation of the full-length C-terminal
tail, which is now seen to fold over to form a hairpin that runs
parallel to the integrin-recognition loop. The RGD loop and the
C-terminal region of echistatin exhibit concerted motions and
form a continuous patch involved in extensive interactions with
both subunits of integrin receptors, providing the molecular basis
for our understanding of the functional synergy between the RGD
loop and the C-terminal sequence of echistatin.
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